eFFECTOR Therapeutics Overview
eFFECTOR Therapeutics Discounted Cash Flow
DCF Analysis for EFTR.
Get informed when a big investor buys or sells
+ FollowFair Value
$-2.09
Current Fair Value
$-2.09
↓ 1044950.0% Downside
Overvalued by 1044950.0% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison